Streamex and BioSig Announce the Successful Closing of Share Exchange Transaction and Executive Leadership Changes Bringing a First-Mover Real World Asset Tokenization Company to the Nasdaq
BioSig Technologies (NASDAQ: BSGM) and Streamex Exchange Corporation have completed their share exchange transaction, transforming into a company focused on real-world asset tokenization, particularly in the commodities sector. The deal positions the combined entity to tap into the $142.85 trillion global commodity market.
Key leadership changes include Streamex's Co-Founder Henry McPhie becoming CEO and joining the Board, while Co-Founder Morgan Lekstrom will serve as Chairman. Former BioSig CEO Anthony Amato will remain on the Board. Notable strategic additions include Frank Giustra, founder of Wheaton Precious Metals and GoldCorp, as Strategic Investor and Advisor on Commodities, and Mathew August as Strategic Advisor on US Capital Markets.
BioSig Technologies (NASDAQ: BSGM) e Streamex Exchange Corporation hanno completato la loro operazione di scambio azionario, trasformandosi in una società focalizzata sulla tokenizzazione di asset reali, in particolare nel settore delle materie prime. L'accordo posiziona l'entità combinata per sfruttare il mercato globale delle materie prime da 142,85 trilioni di dollari.
I principali cambiamenti nella leadership includono il co-fondatore di Streamex, Henry McPhie, che diventa CEO e entra nel Consiglio di Amministrazione, mentre il co-fondatore Morgan Lekstrom assumerà il ruolo di Presidente. L'ex CEO di BioSig, Anthony Amato, rimarrà nel Consiglio. Tra le importanti aggiunte strategiche figurano Frank Giustra, fondatore di Wheaton Precious Metals e GoldCorp, come investitore strategico e consulente per le materie prime, e Mathew August come consulente strategico per i mercati dei capitali statunitensi.
BioSig Technologies (NASDAQ: BSGM) y Streamex Exchange Corporation han completado su transacción de intercambio de acciones, transformándose en una empresa enfocada en la tokenización de activos del mundo real, especialmente en el sector de materias primas. El acuerdo posiciona a la entidad combinada para aprovechar el mercado global de materias primas de 142,85 billones de dólares.
Los cambios clave en el liderazgo incluyen que el cofundador de Streamex, Henry McPhie, se convierte en CEO y se une a la Junta Directiva, mientras que el cofundador Morgan Lekstrom asumirá el cargo de Presidente. El ex CEO de BioSig, Anthony Amato, permanecerá en la Junta. Entre las incorporaciones estratégicas destacadas están Frank Giustra, fundador de Wheaton Precious Metals y GoldCorp, como inversor estratégico y asesor en materias primas, y Mathew August como asesor estratégico en mercados de capital de EE.UU.
BioSig Technologies (NASDAQ: BSGM)와 Streamex Exchange Corporation이 주식 교환 거래를 완료하여, 특히 원자재 분야에서 실제 자산 토큰화에 중점을 둔 회사로 변모했습니다. 이번 거래로 통합된 기업은 142.85조 달러 규모의 글로벌 원자재 시장에 진출할 수 있게 되었습니다.
주요 리더십 변화로는 Streamex 공동 창립자 Henry McPhie가 CEO로 취임하고 이사회에 합류했으며, 공동 창립자 Morgan Lekstrom는 회장직을 맡게 됩니다. 전 BioSig CEO Anthony Amato는 이사회에 남아 있습니다. 전략적 주요 인물로는 Wheaton Precious Metals와 GoldCorp의 창립자인 Frank Giustra가 원자재 분야 전략 투자자 및 고문으로, Mathew August가 미국 자본 시장 전략 고문으로 합류했습니다.
BioSig Technologies (NASDAQ : BSGM) et Streamex Exchange Corporation ont finalisé leur opération d’échange d’actions, se transformant en une entreprise axée sur la tokenisation d’actifs réels, notamment dans le secteur des matières premières. Cette transaction positionne l’entité combinée pour exploiter le marché mondial des matières premières de 142,85 trillions de dollars.
Parmi les changements clés à la tête, le cofondateur de Streamex, Henry McPhie, devient PDG et rejoint le conseil d’administration, tandis que le cofondateur Morgan Lekstrom assumera le rôle de président. L’ancien PDG de BioSig, Anthony Amato, restera au conseil. Parmi les ajouts stratégiques notables figurent Frank Giustra, fondateur de Wheaton Precious Metals et GoldCorp, en tant qu’investisseur stratégique et conseiller en matières premières, ainsi que Mathew August en tant que conseiller stratégique sur les marchés des capitaux américains.
BioSig Technologies (NASDAQ: BSGM) und Streamex Exchange Corporation haben ihren Aktientausch abgeschlossen und sich in ein Unternehmen verwandelt, das sich auf die Tokenisierung realer Vermögenswerte, insbesondere im Rohstoffsektor, konzentriert. Der Deal positioniert das kombinierte Unternehmen, um den 142,85 Billionen US-Dollar schweren globalen Rohstoffmarkt zu erschließen.
Wesentliche Führungsänderungen umfassen, dass Streamex-Mitgründer Henry McPhie CEO wird und dem Vorstand beitritt, während Mitgründer Morgan Lekstrom den Vorsitz übernimmt. Der ehemalige BioSig-CEO Anthony Amato bleibt im Vorstand. Bedeutende strategische Ergänzungen sind Frank Giustra, Gründer von Wheaton Precious Metals und GoldCorp, als strategischer Investor und Berater für Rohstoffe sowie Mathew August als strategischer Berater für die US-Kapitalmärkte.
- Strategic transformation into real-world asset tokenization with access to $142.85T global commodity market
- Addition of high-profile strategic advisors including Frank Giustra (founder of $37B Wheaton Precious Metals)
- Nasdaq listing provides enhanced visibility and access to capital markets
- Experienced leadership team with deep industry expertise in both tokenization and commodities
- Significant business model shift from medical technology to tokenization may create integration challenges
- Potential dilution for existing BSGM shareholders through share exchange
- Execution risks in entering the nascent real-world asset tokenization market
Los Angeles, CA and Vancouver, BC, May 28, 2025 (GLOBE NEWSWIRE) -- BioSig Technologies, Inc. (Nasdaq: BSGM) ("BioSig") and Streamex Exchange Corporation ("Streamex"), collectively referred to as the combined company, today announced successful completion of the previously disclosed share exchange transaction and executive leadership changes, forming a company specializing in the tokenization of real-world assets, with a focus on bringing commodities on-chain.
Key Highlights of the Transaction:
- Streamex Exchange Corporation, a British Columbia corporation, will become a wholly owned subsidiary of BioSig through an exchange of outstanding shares of Streamex for new shares of BioSig common stock.
- The combined company will be led by Mr. Henry McPhie, Co-Founder and CEO of Streamex, who will serve as Chief Executive Officer and join the Board of Directors, guiding the organization through its next phase of growth.
- Mr. Morgan Lekstrom, Co-Founder and Chairman of Streamex, will serve as Chairman of the Board of the combined company.
- Mr. Anthony Amato, current CEO of BioSig, will transition from his role as Chief Executive Officer and continue to support the combined company as a member of its Board of Directors.
- Of highlight, Streamex is strategically positioned within the US
$142.85 1 trillion global commodity market, aiming to unlock new value by bringing commodities on-chain through secure and scalable real world asset tokenization solutions.
Together, Henry and Morgan with Anthony’s support will lead the combined company through its next phase of strategic growth, bringing deep industry expertise and a shared vision for transforming the future of real-world asset tokenization in the commodities space.
CEO of the combined company Henry McPhie commented, “This is a landmark moment for Streamex and a major step forward for the tokenization industry. Joining forces with BioSig and entering the public markets will position us to accelerate growth, scale our technology and expand our influence within the tokenization and commodities industries. I am extremely proud of what the Streamex and BioSig team has been able to accomplish so far and am excited for what is to come.”
Strategic Advisor Additions:
Mr. Frank Giustra has agreed to join as a Strategic Investor and Advisor on Commodities.
- Founder of Wheaton Precious Metals (
$37B ) - Founder of GoldCorp, acquired by Newmont (
$57B ) - Founder of LionsGate Films (
$2B )
Mr. Mathew August has agreed to join as a Strategic Advisor on US Capital Markets.
- Executive Chairman of Atlas Capital Partners a New York, NY based single family office investment firm and merchant bank
- Active Venture Capitalist with significant investments within the Defense Tech, FinTech, Aerospace and other diversified industries
About Streamex Exchange Corporation
Streamex is a real-world asset (RWA) tokenization company focused in the commodities space. With the goal to bring commodity markets on chain, Streamex has developed primary issuance and exchange infrastructure that will revolutionize commodity finance. Streamex is led by a group of highly successful and seasoned executives from financial, commodities and blockchain industries.
Streamex believes the future of finance lies in tokenization, innovative investment strategies, and decentralized markets. By merging advanced financial technologies with blockchain transparency, Streamex has created infrastructure and solutions that enhance liquidity, accessibility, and efficiency. Streamex’s goal is to bridge the gap between traditional finance and the digital economy, unlocking new opportunities for investors and institutions worldwide.
Terms of Share Exchange
- In exchange for
100% of their shares of Streamex, existing Streamex shareholders will be entitled to receive75% of the fully diluted BioSig common stock outstanding on the date of the share exchange agreement. Initially, upon the closing, pursuant to Nasdaq listing rules, the Streamex shareholders will be entitled to receive19.9% of the outstanding BioSig common stock pre-transaction. BioSig will then seek a vote of its current shareholders to approve the transaction; if such approval is obtained, the Streamex shareholders will have the right to receive in the aggregate the full number of shares of BioSig common stock equaling75% of the fully diluted BioSig common stock pre-transaction. - After shareholder approval, if obtained, current BioSig shareholders and holders of common stock equivalents will hold
25% of the fully diluted BioSig common stock outstanding.
Effective immediately, the Board of Directors of the combined company will be comprised of six members, four designated by BioSig, who are Anthony Amato, Chris Baer, Donald F. Browne, Steven E. Abelman and two designated by Streamex, who are Mr. McPhie and Mr. Lekstrom (who will also be Chairman of the combined company’s board).
To the extent required by NASDAQ’s change of control rules and regulations, the combined company will file an initial listing application for its common stock.
Forward Looking Statements
This press release contains “forward-looking statements” within the meaning of the Private Securities Litigation Reform Act of 1995. Such statements may be preceded by the words “intends,” “may,” “will,” “plans,” “expects,” “anticipates,” “projects,” “predicts,” “estimates,” “aims,” “believes,” “hopes,” “potential” or similar words. Forward-looking statements are not guarantees of future performance, are based on certain assumptions, and are subject to various known and unknown risks and uncertainties, many of which are beyond our control. It is possible that our actual results and financial condition may differ, possibly materially, from the anticipated results and financial condition indicated in these forward-looking statements, depending on factors including whether we will be able to realize the benefits of the transaction described herein, whether shareholder approval of the transaction will be obtained and whether we will be able to maintain compliance with Nasdaq’s listing criteria in connection with the described transaction and otherwise. For a discussion of other risks and uncertainties, and other important factors, any of which could cause our actual results to differ from those contained in forward-looking statements, see our filings with the Securities and Exchange Commission, including the section titled “Risk Factors” in our Annual Report on Form 10-K, filed with the SEC on April 15, 2025. We assume no obligation to publicly update or revise our forward-looking statements as a result of new information, future events or otherwise, except as required by law.
Todd Adler BioSig Technologies, Inc. Investor Relations 12424 Wilshire Blvd Ste 745 Los Angeles, CA 90025 tadler@biosigtech.com 203-409-5444 x104 Henry McPhie Co-Founder & CEO of Streamex, CEO of the Combined Company contact@Streamex.com https://www.streamex.com/ https://x.com/streamex
FAQ
What is the strategic rationale behind BioSig's (BSGM) merger with Streamex?
Who will lead the combined BioSig-Streamex company after the merger?
What notable strategic advisors have joined BSGM following the Streamex merger?
How will the BioSig-Streamex merger be structured?
